Mutual Fund Ownership
Ownership as on: Thu, 28 Mar, 2024

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)54.66
% of AUM5.74%

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)40.99
% of AUM5.19%

WhiteOak Capital Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)4.53
% of AUM4.41%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)28.80
% of AUM4.16%

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)8.77
% of AUM3.18%

FAQs about Ajanta Pharmaceuticals share price

Ajanta Pharmaceuticals is trading at 2240.00 as on Thu Mar 28 2024 09:58:00. This is 2.60% upper as compared to its previous closing price of 2183.30.

The market capitalization of Ajanta Pharmaceuticals is 28205.11 Cr as on Thu Mar 28 2024 09:58:00.

The average broker rating on Ajanta Pharmaceuticals is Buy. The breakup of analyst rating is given below -

  • 5 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 1 analysts have given a strong sell rating

The 52 wk high for Ajanta Pharmaceuticals is 2355.05 whereas the 52 wk low is 1136.04

Ajanta Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 35.76
  • Sector P/E: 31.33
  • Dividend Yield: 0.78%
  • D/E ratio: -

Ajanta Pharmaceuticals reported a net profit of 587.98 Cr in 2023.

Recommended For You
Images
Trending Stocks
1,643.05+61.85(3.91%)
7,240.35+217.15(3.09%)
1,048.30-5.30 (-0.50%)
2,976.80-11.05 (-0.37%)